These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 23576077)

  • 1. Squamous cell carcinoma antigen: a potentially useful prognostic marker in squamous cell carcinoma of the anal canal and margin.
    Williams M; Swampillai A; Osborne M; Mawdsley S; Hughes R; Harrison M; Harvey R; Glynne-Jones R;
    Cancer; 2013 Jul; 119(13):2391-8. PubMed ID: 23576077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation of serum squamous cell carcinoma antigen with clinico-pathological features and prognosis of squamous cell carcinoma of uterine cervix].
    Xiong Y; Liang LZ; Zheng M; Wei M; Shen Y
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):29-33. PubMed ID: 17331418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impact of squamous cell carcinoma antigen in patients with recurrent squamous cell carcinoma of the uterine cervix].
    Ma SK; Wu LY; Sun YC; Li B; Zhang HT
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):13-7. PubMed ID: 18366925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Squamous cell carcinoma antigen levels in patients with laryngeal cancer].
    Polberg K; Stepulak A; Stryjecka-Zimmer M; Kupisz K; Zawiślak J
    Pol Merkur Lekarski; 2005 Sep; 19(111):375-6. PubMed ID: 16358876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus.
    Toh E; Wilson J; Sebag-Montefiore D; Botterill I
    Colorectal Dis; 2014 Mar; 16(3):O90-7. PubMed ID: 24148256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal.
    Eng C; Chang GJ; You YN; Das P; Xing Y; Delclos M; Wolff RA; Rodriguez-Bigas MA; Skibber J; Ohinata A; Gould S; Phillips J; Crane CH
    Cancer; 2013 Nov; 119(21):3769-75. PubMed ID: 24037775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Value of Squamous Cell Carcinoma Antigen (SCCAg) in Anal Cancer - A Single-Center Retrospective Analysis.
    Henkenberens C; Toklu H; Tamme C; Bruns F
    Anticancer Res; 2016 Jun; 36(6):3173-7. PubMed ID: 27272844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
    Gaarenstroom KN; Kenter GG; Bonfrer JM; Korse CM; Van de Vijver MJ; Fleuren GJ; Trimbos JB
    Gynecol Oncol; 2000 Apr; 77(1):164-70. PubMed ID: 10739706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of squamous cell carcinoma antigen in the prognostic evaluation, treatment monitoring and followup of patients with penile cancer.
    Zhu Y; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ
    J Urol; 2008 Nov; 180(5):2019-23. PubMed ID: 18801542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.
    Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH
    Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the "squamous cell carcinoma antigen" as marker of epidermoid cancer of the anal canal].
    Fontana X; Lagrange JL; François E; Bourry J; Chauvel P; Sordage M; Lapalus F; Namer M
    Ann Gastroenterol Hepatol (Paris); 1991 Nov; 27(6):293-6. PubMed ID: 1772243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of combined examination of pretreatment serum CYFRA21-1 and SCCAg in cervical cancer patients.
    Xiong Y; Peng XP; Liang LZ; Zheng M; Li JD
    Ai Zheng; 2009 Jan; 28(1):64-7. PubMed ID: 19448420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of brachytherapy in the boost management of anal carcinoma with node involvement (CORS-03 study).
    Moureau-Zabotto L; Ortholan C; Hannoun-Levi JM; Teissier E; Cowen D; Salem N; Lemanski C; Ellis S; Resbeut M
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e135-42. PubMed ID: 23195780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical usage of the squamous cell carcinoma antigen in patients with penile cancer.
    Touloupidis S; Zisimopoulos A; Giannakopoulos S; Papatsoris AG; Kalaitzis C; Thanos A
    Int J Urol; 2007 Feb; 14(2):174-6. PubMed ID: 17302580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification in oral cavity squamous cell carcinoma by preoperative CRP and SCC antigen levels.
    Huang SF; Wei FC; Liao CT; Wang HM; Lin CY; Lo S; Huang JJ; Chen IH; Kang CJ; Chien HT; Chen HH
    Ann Surg Oncol; 2012 Nov; 19(12):3856-64. PubMed ID: 22576068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix.
    Bae SN; Namkoong SE; Jung JK; Kim CJ; Park JS; Kim JW; Lee JM; Kim SJ
    Gynecol Oncol; 1997 Mar; 64(3):418-24. PubMed ID: 9062143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Significance of Cytokeratin 19 and Squamous Cell Cancer Antigen in Histologically Negative Sentinel Lymph Nodes of Cervical Squamous Cell Carcinoma.
    Ren J; Zhou ZL; Xu S; Yang YJ
    Int J Gynecol Cancer; 2016 Nov; 26(9):1679-1685. PubMed ID: 27654256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
    Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic tumor volume predicts disease progression and survival in patients with squamous cell carcinoma of the anal canal.
    Bazan JG; Koong AC; Kapp DS; Quon A; Graves EE; Loo BW; Chang DT
    J Nucl Med; 2013 Jan; 54(1):27-32. PubMed ID: 23236018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.